- Home
- CHRS
as 04-01-2025 4:00pm EST
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 94.0M | IPO Year: | 2014 |
| Target Price: | $5.38 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.25 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.66 - $2.61 | Next Earning Date: | 05-08-2025 |
| Revenue: | $266,959,999 | Revenue Growth: | 3.78% |
| Revenue Growth (this year): | -61.14% | Revenue Growth (next year): | 9.02% |
Latest Coherus BioSciences Inc. News
CHRS Breaking Stock News: Dive into CHRS Ticker-Specific Updates for Smart Investing
GlobeNewswire
11 hours ago
Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes
GlobeNewswire
7 days ago
Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025 American Association for Cancer Research (AACR) Annual Meeting
Simply Wall St.
9 days ago
Statutory Earnings May Not Be The Best Way To Understand Coherus BioSciences' (NASDAQ:CHRS) True Position
TipRanks
18 days ago
Biotech Alert: Searches spiking for these stocks today
Simply Wall St.
18 days ago
Coherus BioSciences Full Year 2024 Earnings: Beats Expectations
Insider Monkey
20 days ago
Coherus BioSciences, Inc. (CHRS): A Bull Case Theory
Thomson Reuters StreetEvents
21 days ago
Q4 2024 Coherus BioSciences Inc Earnings Call
GuruFocus.com
22 days ago
Coherus BioSciences Inc (CHRS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Compare CHRS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CHRS Coherus BioSciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.